Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05772845 · ClinicalTrials.gov registry record · NA
Vaping and Smoking Withdrawal Project
A NA study of Acute Abstinence From Cigarettes vs E-cigarettes (ENDS), sponsored by State University of New York at Buffalo.
- Recruiting
- Registry status
- NA
- Development phase
- 370
- Enrollment target
- 1
- Study location
NCT05772845: Recruiting NA study of Acute Abstinence From Cigarettes vs E-cigarettes (ENDS), sponsored by State University of New York at Buffalo.
NCT05772845 is a NA study of Acute Abstinence From Cigarettes vs E-cigarettes (ENDS) that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 370 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05772845, a NA study of Acute Abstinence From Cigarettes vs E-cigarettes (ENDS), is actively recruiting participants, sponsored by State University of New York at Buffalo.
- RECRUITING
- Registry status
- NA
- Development phase
- 370 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed research, which will systematically and comprehensively characterize the withdrawal among daily vapers compared to daily smokers of combustible cigarettes, filling critical gaps in the understanding of electronic nicotine delivery systems (ENDS) dependence/abuse liability and contributing to the development of therapies for tobacco/nicotine use, the leading preventable cause of death in the US.
Primary Outcome
anger subscale score
Conditions Studied
Interventions
- BEHAVIORAL Acute (24-hour) abstinence
- BEHAVIORAL Ad libitum smoking/vaping
Study Locations (1)
New York
- University at Buffalo - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 370 participants |
| Start Date | 2023-02-14 |
| Est. Completion | 2026-11-30 |
| Phase | NA |
What NCT05772845 shows while recruiting
NCT05772845 is an interventional study that assigns participants to a tested intervention. The registered 370 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).
The record links to 1 condition, with Acute Abstinence From Cigarettes vs E-cigarettes (ENDS) appearing as the primary indexed condition, and to 2 interventions - of which Acute (24-hour) abstinence is the first listed.
NCT05772845 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05772845 about?
NCT05772845 is a clinical study titled "Vaping and Smoking Withdrawal Project". The proposed research, which will systematically and comprehensively characterize the withdrawal among daily vapers compared to daily smokers of combustible cigarettes, filling critical gaps in the understanding of electronic nicotine delivery systems (ENDS) dependence/abuse liability and contributi...
What is the current status of trial NCT05772845?
This trial is currently recruiting. It is a NA study. The enrollment target is 370 participants. The study started on 2023-02-14. Estimated completion is 2026-11-30.
What conditions does trial NCT05772845 study?
This clinical trial studies the following conditions: Acute Abstinence From Cigarettes vs E-cigarettes (ENDS).
What interventions are being tested in trial NCT05772845?
The interventions under investigation include: Acute (24-hour) abstinence (BEHAVIORAL), Ad libitum smoking/vaping (BEHAVIORAL).
Who is sponsoring clinical trial NCT05772845?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05772845 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Abstinence From Cigarettes vs E-cigarettes (ENDS)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05772845's enrollment target sits among peer trials
370 281st of 2000 higher than 1,720 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02332668 · 370 participants · Phase 1
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- NCT04284436 · 370 participants · NA
Study in Parkinson Disease of Exercise
- NCT05026749 · 370 participants · Phase 3
Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
- NCT05125016 · 370 participants · Phase 1
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With Cemiplimab or REGN5678 for Adult Participants With Advanced Prostate Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI